Xu JL - Search Results

1

GPR30 Activation Promotes the Progression of Gastric Cancer and Plays a Significant Role in the Anti-GC Effect of Huaier.

Wang XF, Hu C, Mo SW, Xu JL, Liu Y, Xu HD, Yuan L, Huang L, Yu JF, Cheng XD, Xu ZY. Wang XF, et al. Among authors: xu zy, xu jl, xu hd. J Oncol. 2022 Jan 19;2022:2410530. doi: 10.1155/2022/2410530. eCollection 2022. J Oncol. 2022. PMID: 35096058 Free PMC article.

2

Terphenyllin Suppresses Orthotopic Pancreatic Tumor Growth and Prevents Metastasis in Mice.

Zhang J, Wang W, Zhou Y, Yang J, Xu J, Xu Z, Xu B, Yan L, Cheng XD, Li M, Qin JJ. Zhang J, et al. Front Pharmacol. 2020 Apr 8;11:457. doi: 10.3389/fphar.2020.00457. eCollection 2020. Front Pharmacol. 2020. PMID: 32322210 Free PMC article.

3

The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?

Xu JL, Yuan L, Tang YC, Xu ZY, Xu HD, Cheng XD, Qin JJ. Xu JL, et al. Among authors: xu zy, xu hd. Front Cell Dev Biol. 2020 Dec 3;8:621428. doi: 10.3389/fcell.2020.621428. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33344463 Free PMC article. Review.

4

p-MEK expression predicts prognosis of patients with adenocarcinoma of esophagogastric junction (AEG) and plays a role in anti-AEG efficacy of Huaier.

Yuan L, Mo SW, Xu ZY, Lv H, Xu JL, Guo KB, Hu C, Wang XF, Chen GP, Qin JJ, Cheng XD. Yuan L, et al. Among authors: xu zy, xu jl. Pharmacol Res. 2021 Mar;165:105411. doi: 10.1016/j.phrs.2020.105411. Epub 2021 Jan 2. Pharmacol Res. 2021. PMID: 33401002

5

Prognostic significance of serum tumor marker normalization in the perioperative period for patients with advanced gastric cancer.

Hu C, Zhang Y, Xu J, Chen W, Yu P, Wang Y, Bao Z, Zhang R, Xu Z, Cheng X. Hu C, et al. Ann Transl Med. 2022 Feb;10(3):153. doi: 10.21037/atm-22-109. Ann Transl Med. 2022. PMID: 35284544 Free PMC article.

6

Trametes robiniophila Murr Sensitizes Gastric Cancer Cells to 5-Fluorouracil by Modulating Tumor Microenvironment.

Xu JL, Yuan L, Hu C, Weng CY, Xu HD, Shi YF, Huang L, Ying JE, Xu ZY, Qin JJ, Cheng XD. Xu JL, et al. Among authors: xu zy, xu hd. Front Pharmacol. 2022 May 17;13:911663. doi: 10.3389/fphar.2022.911663. eCollection 2022. Front Pharmacol. 2022. PMID: 35656301 Free PMC article.

7

CD3D Is an Independent Prognostic Factor and Correlates With Immune Infiltration in Gastric Cancer.

Yuan L, Xu J, Shi Y, Jin Z, Bao Z, Yu P, Wang Y, Xia Y, Qin J, Zhang B, Yao Q. Yuan L, et al. Front Oncol. 2022 Jun 1;12:913670. doi: 10.3389/fonc.2022.913670. eCollection 2022. Front Oncol. 2022. PMID: 35719985 Free PMC article.

8

Huaier Inhibits Gastric Cancer Growth and Hepatic Metastasis by Reducing Syntenin Expression and STAT3 Phosphorylation.

Shi Y, Yuan L, Xu J, Xu H, Wang L, Huang L, Xu Z, Cheng X. Shi Y, et al. J Oncol. 2022 Jun 15;2022:6065516. doi: 10.1155/2022/6065516. eCollection 2022. J Oncol. 2022. PMID: 35756080 Free PMC article.

9

Discovery of benzochalcone derivative as a potential antigastric cancer agent targeting signal transducer and activator of transcription 3 (STAT3).

Dong J, Yang J, Yu W, Li H, Cai M, Xu JL, Xu HD, Shi YF, Guan X, Cheng XD, Qin JJ. Dong J, et al. Among authors: xu jl, xu hd. J Enzyme Inhib Med Chem. 2022 Dec;37(1):2004-2016. doi: 10.1080/14756366.2022.2100366. J Enzyme Inhib Med Chem. 2022. PMID: 35844184 Free PMC article.

10

Aberrant Expression TFR1/CD71 in Gastric Cancer Identifies a Novel Potential Prognostic Marker and Therapeutic Target.

Cao J, Hu C, Xu J, Han J, Zhang R, Cao M, Yuan L, Xu Z. Cao J, et al. Evid Based Complement Alternat Med. 2022 Aug 30;2022:4257342. doi: 10.1155/2022/4257342. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36082181 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

571 results

Search Page

Filters